RediNews
ETFs Holding ARNA »    ARNA Historical Stock Prices »
ARNA News Video: Thu, Nov 15, 2018, 12:27 PM — Thursday's ETF Movers: XBI, ITB


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arena Pharmaceuticals is a biopharmaceutical company focused on developing small molecule drugs with receptor pharmacology designed to deliver clinical utility across therapeutic areas. Co.'s investigational clinical programs include: Ralinepag, a selective oral IP receptor agonist intended for the treatment of pulmonary arterial hypertension; Etrasimod, a modulator of the sphingosine 1-phosphate, receptor intended for the treatment of a range of immune and inflammatory conditions; and APD371, an agonist of the cannabinoid-2 receptor intended for the treatment of a range of visceral pain conditions. Arena Pharmaceuticals ® and Arena ® are registered service marks of Co. Self directed investors in Arena Pharmaceuticals Inc will be interested in keeping up with all Arena Pharmaceuticals Inc news they can find, both ARNA news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ARNA. At RediNews, we simplify this task by presenting both ARNA news releases originating from Arena Pharmaceuticals Inc itself, and ARNA news from a variety of media outlets. Visitors can browse this news online and through our ARNA RSS news feed.

ARNA News

ARNA News — Articles, Videos, & Press Releases

Notable Thursday Option Activity: ARNA, BG, KNX
Thursday, May 16, 2019, 3:19 PM — Stock Options Channel
June 28th Options Now Available For Arena Pharmaceuticals (ARNA)
Monday, May 13, 2019, 10:49 AM — Stock Options Channel
United Therapeutics (UTHR) Down Despite Q1 Earnings Beat
Thursday, May 2, 2019, 7:26 AM — Zacks
Noteworthy Thursday Option Activity: ARNA, JPM, STAA
Thursday, April 18, 2019, 3:20 PM — Stock Options Channel
Analysts Forecast 13% Gains Ahead For The Holdings of FYX
Friday, March 15, 2019, 7:35 AM — ETF Channel
United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
Thursday, February 28, 2019, 9:16 AM — Zacks
Arena Pharmaceuticals (ARNA) Beats on Q4 Earnings & Revenues
Wednesday, February 27, 2019, 7:25 AM — Zacks
Implied JKK Analyst Target Price: $224
Tuesday, February 12, 2019, 7:33 AM — ETF Channel
Analysts Forecast 25% Gains Ahead For The Holdings of FYX
Wednesday, January 9, 2019, 7:53 AM — ETF Channel
Interesting ARNA Put And Call Options For February 8th
Friday, January 4, 2019, 10:34 AM — Stock Options Channel
ARNA February 2019 Options Begin Trading
Thursday, December 13, 2018, 11:26 AM — Stock Options Channel
ARNA Crosses Below Key Moving Average Level
Thursday, December 6, 2018, 4:50 PM — Market News Video
Analysts Anticipate 20% Upside For FYC
Monday, December 3, 2018, 8:06 AM — ETF Channel
January 2019 Options Now Available For Arena Pharmaceuticals (ARNA)
Thursday, November 29, 2018, 1:02 PM — Stock Options Channel
ARNA February 2019 Options Begin Trading
Friday, November 16, 2018, 10:44 AM — Stock Options Channel
Noteworthy Thursday Option Activity: RESI, CRMT, ARNA
Thursday, November 15, 2018, 3:22 PM — Stock Options Channel
Interesting ARNA Put And Call Options For December 14th
Thursday, November 1, 2018, 11:56 AM — Stock Options Channel
Analysts Anticipate FYC To Hit $55
Monday, October 29, 2018, 8:05 AM — ETF Channel
Notable Friday Option Activity: WGO, ARNA, RMBS
Friday, October 5, 2018, 3:20 PM — Stock Options Channel
ARNA November 23rd Options Begin Trading
Thursday, October 4, 2018, 11:24 AM — Stock Options Channel
Analysts Predict 10% Upside For The Holdings of FYX
Friday, September 28, 2018, 9:07 AM — ETF Channel
Arena Pharmaceuticals (ARNA) Shares Cross Above 200 DMA
Friday, August 31, 2018, 11:30 AM — Market News Video
Implied PTH Analyst Target Price: $110
Monday, August 27, 2018, 7:21 AM — ETF Channel
Arena Pharmaceuticals Becomes Oversold (ARNA)
Wednesday, August 15, 2018, 4:30 PM — Dividend Channel
Short Interest Declines 11% For ARNA
Friday, August 10, 2018, 1:39 PM — Market News Video
ARNA Crosses Below Key Moving Average Level
Friday, August 3, 2018, 4:43 PM — Market News Video
September 7th Options Now Available For Arena Pharmaceuticals (ARNA)
Thursday, July 26, 2018, 1:01 PM — Stock Options Channel
Arena Pharmaceuticals is Now Oversold (ARNA)
Wednesday, July 25, 2018, 12:00 PM — Dividend Channel
How The Pieces Add Up: JKK Headed For $224
Wednesday, July 25, 2018, 7:51 AM — ETF Channel
Noteworthy Tuesday Option Activity: ADSK, ALNY, ARNA
Tuesday, July 17, 2018, 3:46 PM — Stock Options Channel
Interesting ARNA Put And Call Options For August 17th
Thursday, June 28, 2018, 10:33 AM — Stock Options Channel
First Week of September 21st Options Trading For Arena Pharmaceuticals (ARNA)
Wednesday, June 27, 2018, 10:34 AM — Stock Options Channel
Notable Thursday Option Activity: GS, ARNA, LFGR
Thursday, June 21, 2018, 3:38 PM — Stock Options Channel
Implied PTH Analyst Target Price: $102
Thursday, June 14, 2018, 7:49 AM — ETF Channel
Noteworthy Tuesday Option Activity: IMMR, ARNA, SAGE
Tuesday, June 12, 2018, 3:18 PM — Stock Options Channel
ARNA is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

ALGN News
INSM News
RMTI News
STE News
BRLI News
OSIR News
IART News
MD News
ASEI News
HLS News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ARNA News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.